PBK was reported to regulate the expression of androgen receptor (AR) protein, and the overexpression of PBK in aggressive prostate cancer was reported to be associated with early biochemical relapse and poor clinical manifestations (Warren et al., 2019). Here, AR is linked to prostate cancer.